Novavax Inc. buy kostojunior
Start price
09.01.25
/
0%
€9.64
Target price
09.01.26
-
Performance (%)
-15.48%
End price
18.01.25
€8.15
Summary
This prediction ended on 18.01.25 with a price of €8.15. The price of Novavax Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.48%. This prediction was marked as speculative and is excluded from kostojunior's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | -5.548% | -5.548% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
According to kostojunior what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Cons
Comments by kostojunior for this prediction
In the thread Novavax Inc. diskutieren
Buy Novavax Inc.
In the thread Trading Novavax Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by kostojunior for Novavax Inc.
Novavax Inc.
Start price
Target price
Perf. (%)
€12.15
13.05.24
13.05.24
-
13.05.25
13.05.25
16.83%
25.05.24
25.05.24
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Novavax Inc.
Start price
Target price
Perf. (%)
€212.55
05.09.21
05.09.21
€333.00
05.09.22
05.09.22
-85.70%
06.09.22
06.09.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model